×
About 110 results

ALLMedicine™ AIDS-related Lymphomas Center

Research & Reviews  55 results

Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086
PloS One; Manyau MCP, Mudzviti T et. al.

Sep 17th, 2020 - Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings an...

AIDS-Related Lymphomas
https://emedicine.medscape.com/article/1389907-overview

Aug 13th, 2019 - Practice Essentials AIDS-related lymphoma (ARL) is usually an AIDS-defining malignancy in patients infected with human immunodeficiency virus (HIV). ARLs comprise a narrow spectrum of histologic types consisting almost exclusively of aggressive B-...

AIDS-related lymphomas: Treatment of systemic lymphoma
https://www.uptodate.com//contents/aids-related-lymphomas-treatment-of-systemic-lymphoma
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, a condition known to predispose persons to develop neoplasms. As the lifespan of HIV-infected patients has increased, malignancies have become a known...

Pulmonary manifestations of AIDS-related lymphomas
https://www.uptodate.com//contents/pulmonary-manifestations-of-aids-related-lymphomas
Michael Ieong

INTRODUCTION Human immunodeficiency virus (HIV) infection is associated with an increased incidence of lymphoma. The majority of AIDS-related lymphomas are aggressive, non-Hodgkin lymphoma (NHL) of B cell origin; nearly 60 percent are diffuse larg...

AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology
https://www.uptodate.com//contents/aids-related-lymphomas-epidemiology-risk-factors-and-pathobiology
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, which predisposes to development of cancers [ 1-4 ]. As the lifespan of HIV-infected patients has lengthened, malignancies increasingly contribute to ...

see more →

Clinicaltrials.gov  55 results

Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086
PloS One; Manyau MCP, Mudzviti T et. al.

Sep 17th, 2020 - Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings an...

AIDS-Related Lymphomas
https://emedicine.medscape.com/article/1389907-overview

Aug 13th, 2019 - Practice Essentials AIDS-related lymphoma (ARL) is usually an AIDS-defining malignancy in patients infected with human immunodeficiency virus (HIV). ARLs comprise a narrow spectrum of histologic types consisting almost exclusively of aggressive B-...

AIDS-related lymphomas: Treatment of systemic lymphoma
https://www.uptodate.com//contents/aids-related-lymphomas-treatment-of-systemic-lymphoma
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, a condition known to predispose persons to develop neoplasms. As the lifespan of HIV-infected patients has increased, malignancies have become a known...

Pulmonary manifestations of AIDS-related lymphomas
https://www.uptodate.com//contents/pulmonary-manifestations-of-aids-related-lymphomas
Michael Ieong

INTRODUCTION Human immunodeficiency virus (HIV) infection is associated with an increased incidence of lymphoma. The majority of AIDS-related lymphomas are aggressive, non-Hodgkin lymphoma (NHL) of B cell origin; nearly 60 percent are diffuse larg...

AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology
https://www.uptodate.com//contents/aids-related-lymphomas-epidemiology-risk-factors-and-pathobiology
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, which predisposes to development of cancers [ 1-4 ]. As the lifespan of HIV-infected patients has lengthened, malignancies increasingly contribute to ...

see more →